Cerence Inc.

NASDAQ:CRNC

3.06 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 70.53967.825138.33580.76461.6668.39383.65858.14489.04186.2894.42698.07696.80198.66294.96490.88274.8186.49577.45982.4977.56970.30472.48475.35672.17767.49661.955
Cost of Revenue 20.65521.43726.33523.02820.93825.01426.18324.38324.25224.30624.22724.12723.83526.22426.88125.58427.60328.7325.93427.09823.67524.44424.20722.24319.48517.91617.788
Gross Profit 49.88446.38811257.73640.72243.37957.47533.76164.78961.97470.19973.94972.96672.43868.08365.29847.20757.76551.52555.39253.89445.8648.27753.11352.69249.5844.167
Gross Profit Ratio 0.7070.6840.810.7150.660.6340.6870.5810.7280.7180.7430.7540.7540.7340.7170.7180.6310.6680.6650.6710.6950.6520.6660.7050.730.7350.713
Reseach & Development Expenses 31.18431.84633.30635.14330.20228.49429.49425.30826.0429.97625.79228.70530.3728.86424.09122.00122.04121.34623.51123.71722.97522.56123.80822.74322.11518.92317.176
General & Administrative Expenses 9.83116.65912.79311.4513.01919.17714.25710.71210.61413.87.52718.41613.17312.95611.61712.9314.26110.71211.4838.286.2375.6895.7214.9154.8424.435.686
Selling & Marketing Expenses 5.2085.6196.0715.8484.2778.2179.1628.6118.2998.3095.87910.5869.5349.5558.8988.5699.187.7067.9438.7048.2329.7999.4458.3537.6856.4988.017
SG&A 15.03922.27818.86417.29817.29627.39423.41919.32318.91322.10913.40629.00222.70722.51120.51521.49923.44118.41819.42616.98414.46915.48815.16613.26812.52710.92813.703
Other Expenses 0.626-0.0251.422-1.649-2.032.3942.352.3652.8623.135-0.2520.1310.1733.496-2.237-2.953-20.4460.226-0.1460.233-0.150.266-0.0160.05000
Operating Expenses 46.22354.12452.71552.99848.05158.28255.26346.99647.81555.2242.35260.87656.25754.55847.76446.66848.60242.88946.06843.82840.57641.18142.10639.14443.98837.74438.696
Operating Income 3.661-7.73658.583.896-8.501-14.9036.795-13.23515.7776.2822.93210.75814.94917.34320.27214.118-4.69612.006-2.0974.1463.2610.1682.80910.73712.65616.88310.289
Operating Income Ratio 0.052-0.1140.4230.048-0.138-0.2180.081-0.2280.1770.0730.2430.110.1540.1760.2130.155-0.0630.139-0.0270.050.0420.0020.0390.1420.1750.250.166
Total Other Income Expenses Net -359.757-258.5930.717-2.491-3.202-7.48-7.703-219.555-4.05-3.311-5.167-2.184-1.5872.959-2.284-7.465-23.747-2.644-7.7-7.185-10.207-4.245-3.378-3.182-3.952-5.047-4.818
Income Before Tax -356.096-266.32958.1980.346-13.444-22.383-0.908-232.7911.7272.96919.3437.50211.86217.37914.2547.493-30.655.777-8.764.3793.1110.4342.79310.7878.70411.8365.471
Income Before Tax Ratio -5.048-3.9270.4210.004-0.218-0.327-0.011-4.0040.1320.0340.2050.0760.1230.1760.150.082-0.410.067-0.1130.0530.040.0060.0390.1430.1210.1750.088
Income Tax Expense -42.55311.64734.34111.8983.0113.7061.25-2.663110.9943.4450.299-0.4896.0646.216-7.3840.676-2.469-6.7183.002-89.9381.341-0.020.5382.1632.172.37324.211
Net Income -313.543-277.97623.857-11.552-16.455-26.089-2.158-230.127-99.267-0.47619.0447.9915.79811.16321.6386.817-28.18112.495-11.76294.3171.770.4542.2558.6246.5349.463-18.74
Net Income Ratio -4.445-4.0980.172-0.143-0.267-0.381-0.026-3.958-1.115-0.0060.2020.0810.060.1130.2280.075-0.3770.144-0.1521.1430.0230.0060.0310.1140.0910.14-0.302
EPS -7.5-6.660.58-0.29-0.41-0.65-0.054-5.84-2.53-0.0120.490.210.150.30.560.19-0.770.35-0.332.590.0490.0130.0620.240.180.26-0.515
EPS Diluted -7.5-6.660.53-0.29-0.41-0.65-0.054-5.84-2.53-0.0120.470.20.150.280.530.17-0.770.34-0.332.590.0490.0130.0620.240.180.26-0.515
EBITDA 6.326-5.03864.8257.207-5.034-7.64111.803-10.53422.01813.16734.89516.41424.24528.71525.72423.036-14.0722.95812.95122.10920.11612.17313.50124.87520.56621.99915.354
EBITDA Ratio 0.09-0.0740.4690.089-0.082-0.1120.141-0.1810.2470.1530.370.1670.250.2910.2710.253-0.1880.2650.1670.2680.2590.1730.1860.330.2850.3260.248